← Back to Clinical Trials
Recruiting NCT06961591

NCT06961591 Cooking Skills to Improve Long-Term Weight Loss in Young Adults With Intellectual Disabilities

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06961591
Status Recruiting
Phase
Sponsor University of Kansas Medical Center
Condition Intellectual Disability
Study Type INTERVENTIONAL
Enrollment 114 participants
Start Date 2025-05-19
Primary Completion 2028-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 35 Years
Study Type INTERVENTIONAL
Interventions
Weight Loss Plus CookingTraditional Weight Loss

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 114 participants in total. It began in 2025-05-19 with a primary completion date of 2028-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this study is to see if adding hands-on cooking classes to a weight management program (called Chef-ID) helps young adults with intellectual disabilities lose more weight and keep it off compared to a standard weight loss program. The study will last 24 months and include three phases: 6 months of active support, 12 months of maintenance, and 6 months with no contact. The investigators will look at how much weight participants lose over the first 18 months. Changes in cooking skills, body fat, health markers (like blood pressure and cholesterol), daily living skills, and caregiver stress will be tracked. Finally, factors that might help or prevent weight loss, and how changes in weight and body fat are linked to overall health will be explored. This research will help inform on how to better support healthy lifestyles for people with intellectual disabilities.

Eligibility Criteria

Inclusion Criteria: 1. Diagnosis of mild-to-moderate intellectual disability (ID). 2. 18-35 years of age. 3. BMI \>24.9, Body weight \<350lbs. 4. Sufficient functional ability to understand directions, communicate preferences, e.g., foods, wants, and can communicate through spoken language e.g., request more to eat/drink, asks for assistance with food preparation. 5. Living at home with a parent/guardian, or in a supported living environment with a caregiver who assists with food shopping, meal planning, and meal preparation and agrees to serve as a study partner. 6. Plan to attend all study required visits over the next 24 mos. Exclusion Criteria: 1. Unable to participate in PA. 2. Insulin dependent diabetes as this condition requires medical monitoring beyond the scope of this study. 3. Participation in a weight management program involving diet, PA, or pharmacotherapy in the past 6 mos. 4. Diagnosis of Prader-Willi Syndrome. 5. Pregnancy during the previous 6 mos., currently lactating or planned pregnancy in the following 24 mos. Participants who become pregnant will be removed from the study and referred to appropriate agencies for consultation. 6. Serious medical risk, e.g., cancer, recent heart attack, stroke, angioplasty as determined by the PCP. 7. Unwilling to be randomized. 8. Unable to participate in small group, in-person instruction. 9. Use of wheelchair or power chair as primary locomotion.

Contact & Investigator

Central Contact

Lauren Ptomey, PhD

✉ lptomey@kumc.edu

📞 913-588-7983

Frequently Asked Questions

Who can join the NCT06961591 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 35 Years, studying Intellectual Disability. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06961591 currently recruiting?

Yes, NCT06961591 is actively recruiting participants. Contact the research team at lptomey@kumc.edu for enrollment information.

Where is the NCT06961591 trial being conducted?

This trial is being conducted at Kansas City, United States.

Who is sponsoring the NCT06961591 clinical trial?

NCT06961591 is sponsored by University of Kansas Medical Center. The trial plans to enroll 114 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology